AT
Aptevo Therapeutics Inc.
SEC filingPharmaceuticals · Seattle, WA
Amount raised$3.5Msold at filing
Total offering$3.5M
Investors in the raise3count reported to the SEC
FiledAug 26, 2026first sale Aug 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Barbara J Lopez KunzDirector
Daphne L TaylorExecutive Officer
Zsolt J HarsanyiDirector
Grady J Grant IIIDirector
John E NiederhuberDirector
Jeffrey G LamotheExecutive Officer, Director
Daniel J Abdun-NabiDirector
Marvin L WhiteExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.